KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Asset Writedowns and Impairment (2022 - 2025)

Guardant Health's Asset Writedowns and Impairment history spans 3 years, with the latest figure at -$5.0 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment changed N/A year-over-year to -$5.0 million; the TTM value through Sep 2025 reached $5.0 million, changed N/A, while the annual FY2023 figure was $29.1 million, 452.25% up from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was -$5.0 million at Guardant Health, down from $5.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $23.6 million in Q2 2023 and bottomed at -$5.0 million in Q4 2025.
  • The 3-year median for Asset Writedowns and Impairment is $5.3 million (2022), against an average of $6.9 million.